Industry News
Opthea Announces Leadership Changes as it Prepares for Phase 3 Data on Sozinibercept

Opthea has announced key leadership appointments to strengthen its commercial and clinical capabilit...

read more
Opthea Announces Leadership Changes as it Prepares for Phase 3 Data on Sozinibercept
September 06, 2924
BlueRock Therapeutics Receives FDA Clearance for OpCT-001 IND Application

BlueRock Therapeutics, a subsidiary of Bayer, announced that the FDA has cleared its investigational...

read more
BlueRock Therapeutics Receives FDA Clearance for OpCT-001 IND Application
September 05, 2924
Atsena Therapeutics Publishes 12-Month Data on ATSN-101 for LCA1

Atsena Therapeutics announced that 12-month safety and efficacy data from its Phase I/II trial of AT...

read more
Atsena Therapeutics Publishes 12-Month Data on ATSN-101 for LCA1
September 06, 2024
Haag-Streit Introduces METIS Ophthalmic Microscope System

Haag-Streit has unveiled the METIS Ophthalmic Microscope System, a state-of-the-art innovation desig...

read more
Haag-Streit Introduces METIS Ophthalmic Microscope System
September 03, 2024
Eye Color-Changing Drops: The Dangerous Trend Ophthalmologists Urge You to Avoid

These products, popularized on social media platforms like TikTok, are unproven, unregulated, and co...

read more
Eye Color-Changing Drops: The Dangerous Trend Ophthalmologists Urge You to Avoid
September 02, 2024
ESCRS 2024: Insights From Ophthalmic Leaders with Dr. Filomena Ribeiro

Filomena Ribeiro is the Chair of the Ophthalmology Department at Hospital da Luz Lisbon. Join our in...

read more
ESCRS 2024: Insights From Ophthalmic Leaders with Dr. Filomena Ribeiro
August 26, 2024
Visionix Unveils VX 610 Automated Fundus Camera for Diabetic Retinopathy Screening

The VX 610 features auto alignment, auto focus, and auto capture, allowing for consistent, high-qual...

read more
Visionix Unveils VX 610 Automated Fundus Camera for Diabetic Retinopathy Screening
August 22, 2024
Opus Genetics Receives FDA Rare Pediatric Disease Designation for OPGx-LCA5 Gene Therapy

Opus Genetics has announced that FDA has granted Rare Pediatric Disease (RPD) designation for its oc...

read more
Opus Genetics Receives FDA Rare Pediatric Disease Designation for OPGx-LCA5 Gene Therapy
August 20, 2024
ESCRS 2024: Insights From Ophthalmic Leaders with Dr. H. Burkhard Dick

Dr. Dick was one of the first ophthalmic surgeons in Europe to utilize femtosecond laser technology ...

read more
ESCRS 2024: Insights From Ophthalmic Leaders with Dr. H. Burkhard Dick
August 20, 2024
Sandoz Receives FDA Approval for ENZEEVU™, Expanding Ophthalmology Biosimilar Portfolio

This approval strengthens Sandoz's U.S. biosimilar portfolio, offering a cost-effective alternative ...

read more
Sandoz Receives FDA Approval for ENZEEVU™, Expanding Ophthalmology Biosimilar Portfolio
August 20, 2024
More